These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25876005)

  • 1. Ribonucleotide reductase-mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure.
    Kadota S; Carey J; Reinecke H; Leggett J; Teichman S; Laflamme MA; Murry CE; Regnier M; Mahairas GG
    Eur J Heart Fail; 2015 Aug; 17(8):772-81. PubMed ID: 25876005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility.
    Kolwicz SC; Odom GL; Nowakowski SG; Moussavi-Harami F; Chen X; Reinecke H; Hauschka SD; Murry CE; Mahairas GG; Regnier M
    Mol Ther; 2016 Feb; 24(2):240-250. PubMed ID: 26388461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.
    Fish KM; Ladage D; Kawase Y; Karakikes I; Jeong D; Ly H; Ishikawa K; Hadri L; Tilemann L; Muller-Ehmsen J; Samulski RJ; Kranias EG; Hajjar RJ
    Circ Heart Fail; 2013 Mar; 6(2):310-7. PubMed ID: 23271792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac myosin activators: up and coming.
    Psotka MA; Teerlink JR
    Eur J Heart Fail; 2015 Aug; 17(8):750-2. PubMed ID: 26179667
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous AAV8 Encoding Urocortin-2 Increases Function of the Failing Heart in Mice.
    Lai NC; Gao MH; Giamouridis D; Suarez J; Miyanohara A; Parikh J; Hightower S; Guo T; Dillmann W; Kim YC; Diaz-Juarez J; Hammond HK
    Hum Gene Ther; 2015 Jun; 26(6):347-56. PubMed ID: 25760560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Myosin Activation with Gene Therapy Produces Sustained Inotropic Effects and May Treat Heart Failure with Reduced Ejection Fraction.
    Teichman SL; Thomson KS; Regnier M
    Handb Exp Pharmacol; 2017; 243():447-464. PubMed ID: 27590227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.
    Pleger ST; Shan C; Ksienzyk J; Bekeredjian R; Boekstegers P; Hinkel R; Schinkel S; Leuchs B; Ludwig J; Qiu G; Weber C; Raake P; Koch WJ; Katus HA; Müller OJ; Most P
    Sci Transl Med; 2011 Jul; 3(92):92ra64. PubMed ID: 21775667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs.
    Brenner GB; Giricz Z; Garamvölgyi R; Makkos A; Onódi Z; Sayour NV; Gergely TG; Baranyai T; Petneházy Ö; Kőrösi D; Szabó GP; Vago H; Dohy Z; Czimbalmos C; Merkely B; Boldin-Adamsky S; Feinstein E; Horváth IG; Ferdinandy P
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33938885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-1 gene transfer improves cardiac function in a large-animal model of heart failure.
    Tilemann L; Lee A; Ishikawa K; Aguero J; Rapti K; Santos-Gallego C; Kohlbrenner E; Fish KM; Kho C; Hajjar RJ
    Sci Transl Med; 2013 Nov; 5(211):211ra159. PubMed ID: 24225946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based delivery of dATP via gap junctions enhances cardiac contractility.
    Lundy SD; Murphy SA; Dupras SK; Dai J; Murry CE; Laflamme MA; Regnier M
    J Mol Cell Cardiol; 2014 Jul; 72():350-9. PubMed ID: 24780238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved function of the failing rat heart by regulated expression of insulin-like growth factor I via intramuscular gene transfer.
    Lai NC; Tang T; Gao MH; Saito M; Miyanohara A; Hammond HK
    Hum Gene Ther; 2012 Mar; 23(3):255-61. PubMed ID: 22017392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
    Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of Cardiac Myosin Activation with 2-deoxy-ATP to Treat Heart Failure via an Experimental Ribonucleotide Reductase-Based Gene Therapy.
    Thomson KS; Odom GL; Murry CE; Mahairas GG; Moussavi-Harami F; Teichman SL; Chen X; Hauschka SD; Chamberlain JS; Regnier M
    JACC Basic Transl Sci; 2016 Dec; 1(7):666-679. PubMed ID: 28553667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study.
    Santos-Gallego CG; Requena-Ibanez JA; San Antonio R; Garcia-Ropero A; Ishikawa K; Watanabe S; Picatoste B; Vargas-Delgado AP; Flores-Umanzor EJ; Sanz J; Fuster V; Badimon JJ
    JACC Cardiovasc Imaging; 2021 Feb; 14(2):393-407. PubMed ID: 33129742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure.
    Ishikawa K; Fish KM; Tilemann L; Rapti K; Aguero J; Santos-Gallego CG; Lee A; Karakikes I; Xie C; Akar FG; Shimada YJ; Gwathmey JK; Asokan A; McPhee S; Samulski J; Samulski RJ; Sigg DC; Weber T; Kranias EG; Hajjar RJ
    Mol Ther; 2014 Dec; 22(12):2038-2045. PubMed ID: 25023328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction.
    Bauersachs J; Galuppo P; Fraccarollo D; Christ M; Ertl G
    Circulation; 2001 Aug; 104(9):982-5. PubMed ID: 11524389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model.
    Weber C; Neacsu I; Krautz B; Schlegel P; Sauer S; Raake P; Ritterhoff J; Jungmann A; Remppis AB; Stangassinger M; Koch WJ; Katus HA; Müller OJ; Most P; Pleger ST
    Gene Ther; 2014 Feb; 21(2):131-8. PubMed ID: 24305416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of genetic transfection on calcium cycling pathways mediated by double-stranded adeno-associated virus in postinfarction remodeling.
    Katz MG; Gubara SM; Hadas Y; Weber T; Kumar A; Eliyahu E; Bridges CR; Fargnoli AS
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1809-1819.e3. PubMed ID: 31679707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.